The role of particle therapy in the treatment of locally recurrent rectal cancer: a systematic review.

In 30 seconds

This systematic review evaluated the role of particle therapy in treating locally recurrent rectal cancer, particularly in patients with unresectable or inoperable cases. The review identified 32 studies and concluded that both stereotactic body radiation therapy (SBRT) and particle beam therapy allow for higher radiation doses without increased toxicity, providing a curative alternative to surgery.

Key findings

• SBRT and particle beam therapy enable significantly higher radiation doses to targets without increased treatment-related toxicities.
• Particle beam therapy is suitable for larger, complex recurrences spanning multiple anatomical compartments.
• SBRT is recommended for small local and nodal recurrences.

Why it matters

Understanding the effectiveness of particle therapy and SBRT in managing unresectable rectal cancer can help clinicians offer alternative treatment options that may improve patient outcomes and reduce morbidity associated with surgical interventions.